Skip to main content
Home

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges
  • Open Education

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges
  • Open Education

Artemisinin Resistance

Series
Translational Medicine
Video Audio Embed
Artemisinins are very poweful tools in the treatment of malaria, and the emerging loss of their activity has the potential to create a major public health problem.
MALARIA TREATMENT

Dr Charlie Woodrow is based at MORU in Bangkok, Thailand, where he coordinates clinical and laboratory studies on resistance to artemisinins. Bringing together diverse datasets of clinical, in vitro and molecular data has helped better understand the emerging resistance, particularly in Myanmar.

More in this series

View Series
Journey of a Molecular Detective; David Sherratt

The ethics of research

Identifying and addressing ethical issues are key to the success of any clinical trials, particularly when working with vulnerable populations.
Previous
Journey of a Molecular Detective; David Sherratt

Sharing data to fight malaria

Over 250 Institutions participate in the effort of sharing data on the efficacy of antimalarial drugs, which involves standardising and re-analysing data.
Next
Licence
Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/

Episode Information

Series
Translational Medicine
People
Charlie Woodrow
Keywords
malaria
artemisinin resistance
thailand
Department: Nuffield Department of Clinical Medicine
Date Added: 05/10/2015
Duration: 00:06:25

Subscribe

Apple Podcast Video Apple Podcast Audio Audio RSS Feed Video RSS Feed

Download

Download Video Download Audio

Footer

  • About
  • Accessibility
  • Contribute
  • Copyright
  • Contact
  • Privacy
'Oxford Podcasts' Twitter Account @oxfordpodcasts | MediaPub Publishing Portal for Oxford Podcast Contributors | Upcoming Talks in Oxford | © 2011-2022 The University of Oxford